Abstract
Surveillance is the key of controling the COVID-19 pandemic, and it typically suffers from reporting delays and thus can be misleading. Previous methods for adjusting reporting delays are not particularly appropriate for line list data, which usually have lots of missing values that are non-ignorable for modeling reporting delays. In this paper, we develop a Bayesian approach that dynamically integrates imputation and estimation for line list data. We show this Bayesian approach lead to accurate estimates of the epidemic curve and time-varying reproductive numbers and is robust to deviations from model assumptions. We apply the Bayesian approach to a COVID-19 line list data in Massachusetts and find the reproductive number estimates correspond more closely to the control measures than the ones based on the reported curve.
Competing Interest Statement
The authors have declared no competing interest.
Clinical Trial
This is not a clinic trial study
Funding Statement
This work was funded by NIH R01 GM122876. The funding body had no role in the design and conduct of the study; collection, management, analysis, and interpretation of the data; preparation, review, or approval of the manuscript; and decision to submit the manuscript for publication
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Reviewed by the Institutional Review Board at Boston University, this study is not deemed as human subjects research and does not require IRB approval.
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes